Clinical Trial Update: Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of Glucodia on glucose parameters, triglycerides, and body weight has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Metabolic Syndrome
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucodia™

Snippet

Sponsor: KGK Science Inc. | Conditions: Glucose Parameters, Triglycerides | Phase 2 | Status: COMPLETED